F092 Think Like an Expert about Ichthyosis
DESCRIPTION
This session will be a lively, highly interactive discussion of challenging ichthyosis/epidermal differentiation disorder (EDD) patient cases and updates and controversies in the field. Audience members will have a unique opportunity to observe how complex cases are approached by experts in their daily practice, as well as interact with and ask questions of these experts. A patient advocate will be present to provide the patient perspective.
LEARNING OBJECTIVES
Develop an approach to managing patients with unfamiliar, uncommon, and complex skin disease.
Order appropriate genetic testing for patients with ichthyoses/epidermal differentiation disorders and other inherited skin conditions.
Locate educational and support resources for patients affected by ichthyosis and their families
DIRECTOR
Cheryl Marie Bayart, MD, FAAD
SPEAKERS
Lihi Atzmony, MD, IFAAD
Denise Gass
Antoni Gostynski, MD, PhD, MSc, IFAAD
Juliette Mazereeuw-Hautier
Ryland Mortlock
Amy S. Paller, MD, FAAD
Northwestern University
Janice Schwartz
PC Project (Pachyonychia Congenita Project
DISCLOSURES
Lihi Atzmony, MD, IFAAD
No financial relationships exist with ineligible companies.
Cheryl Marie Bayart, MD, FAAD
Abeona Therapeutics – Advisory Board(Honoraria);
Denise Gass
No financial relationships exist with ineligible companies.
Antoni Gostynski, MD, PhD, MSc, IFAAD
AbbVie – Advisory Board(Honoraria); Almirall – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); La Roche-Posay – Other(Grants/Research Funding); Leo Foundation – Other(Grants/Research Funding); Leo Pharma – Advisory Board(Honoraria); Novo Nordisk A/S – Stockholder Public Company(Stock); Pfizer – Stockholder Public Company(Stock); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Stockholder Public Company(Stock);
Juliette Mazereeuw-Hautier
No financial relationships exist with ineligible companies.
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Janice Schwartz
No financial relationships exist with ineligible companies.